Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hofseth Biocare ASA ( (HOFBF) ) just unveiled an update.
Hofseth BioCare ASA has announced its Annual General Meeting for 2025, highlighting its commitment to sustainability and innovation in health products derived from salmon industry byproducts. The company’s focus on scientific research and patent-backed products positions it strongly in the health and wellness market, with significant implications for stakeholders, including the development of potential therapeutics through its biotech spinoff.
More about Hofseth Biocare ASA
Hofseth BioCare ASA is a Norwegian company specializing in consumer and pet health products, focusing on sustainability and the efficient use of natural resources. The company transforms byproducts from the salmon industry into health-improving ingredients, such as ProGo®, OmeGo®, and CalGo®, which are backed by scientific research and have led to several patents and the creation of a biotech spinoff, HBC Immunology.
YTD Price Performance: 55.00%
Average Trading Volume: 400
Technical Sentiment Signal: Buy
Current Market Cap: $76.99M
Learn more about HOFBF stock on TipRanks’ Stock Analysis page.